Lianghui Zhang

1.2k citations
20 papers · 794 indexed · h-index 13
Topics
COVID-19 Clinical Research Studies (4 papers)SARS-CoV-2 and COVID-19 Research (3 papers)Immune cells in cancer (3 papers)

In The Last Decade

Lianghui Zhang

18 papers receiving 790 citations

Peers

Lianghui Zhang
Comparison fields: 5 of 86
  • Molecular Biology 482
  • Cardiology and Cardiovascular Medicine 119
  • Immunology 115
  • Infectious Diseases 104
  • Pulmonary and Respiratory Medicine 100
Replace Yanfeng Zhong with:
Yanfeng Zhong China
Chirosree Bandyopadhyay United States
Michelle L. D’Antoni United States
Fu‐Sheng Chou United States
Sagi Tshori Israel
David Heinzmann Germany
Naveed Akbar United Kingdom
Szandor Simmons Germany
Kevin Kruse United States
Najat Hajji Netherlands
Lianghui Zhang relative to Yanfeng Zhong China Yanfeng Zhong's profile →
Citations per field
00.5×3.0×
Yanfeng Zhong · 1×
Citations per year

Countries citing papers authored by Lianghui Zhang

Since Specialization
Citations

This map shows the geographic impact of Lianghui Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lianghui Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lianghui Zhang more than expected).

Fields of papers citing papers by Lianghui Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lianghui Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lianghui Zhang. The network helps show where Lianghui Zhang may publish in the future.

Co-authorship network of co-authors of Lianghui Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Lianghui Zhang. A scholar is included among the top collaborators of Lianghui Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lianghui Zhang. Lianghui Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 1
3 18
4 0
5 7
6 53
7 44
8 31
9 5
10 0
11 42
12 23
13 4
14 203
15 88
16 28
17 21
18 123
19 78
20 22

About Lianghui Zhang

Lianghui Zhang is a scholar working on Immunology, Infectious Diseases and Molecular Biology, having authored 20 papers that have together received 794 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Immune cells in cancer (3 papers). The work is most often cited by research in Molecular Biology (482 citations), Infectious Diseases (104 citations) and Cancer Research (83 citations). Lianghui Zhang has collaborated with scholars based in United States, China and Hong Kong. Frequent co-authors include Asrar B. Malik, Jalees Rehman, Péter T. Tóth, Ankit Jambusaria, Sundeep Malik, Alan V. Smrcka, Zhigang Hong, Shubhi Srivastava, Yang Dai and Arundhati Jana. Their work appears in journals such as Cell, Journal of Biological Chemistry and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026